US 11058664
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted A61KA61K31/343A61K31/352
Quick answer
US patent 11058664 (In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors) held by Provectus Pharmatech, Inc. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/343, A61K31/352, A61K31/365, A61K31/4745